Skip to main content
Supplement ScienceSupplementScience

Types of Phosphatidylcholine: Forms & Bioavailability

Evidence:Moderate
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Forms Comparison

FormBioavailabilityBest For
Polyenylphosphatidylcholine (PPC) CapsulesModerate-HighTargeted liver support — the pharmaceutical-grade form used in clinical trials (300mg PPC per capsule typical)
Soy Lecithin Granules/SoftgelsModerateGeneral supplementation — contains ~20-25% phosphatidylcholine along with other phospholipids; less concentrated
Sunflower LecithinModerateSoy-free alternative — allergen-friendly option with similar phospholipid profile to soy lecithin

Polyenylphosphatidylcholine (PPC) Capsules

Bioavailability: Moderate-High. Best for: Targeted liver support — the pharmaceutical-grade form used in clinical trials (300mg PPC per capsule typical).

Soy Lecithin Granules/Softgels

Bioavailability: Moderate. Best for: General supplementation — contains ~20-25% phosphatidylcholine along with other phospholipids; less concentrated.

Sunflower Lecithin

Bioavailability: Moderate. Best for: Soy-free alternative — allergen-friendly option with similar phospholipid profile to soy lecithin.

Full Phosphatidylcholine Guide

References

  1. AnimalLieber CS, DeCarli LM, Mak KM, Kim CI, Leo MA (1990). Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin. Hepatology. DOI PubMed
  2. RCTLieber CS, Weiss DG, Groszmann R, Paronetto F, Schenker S (2003). II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease. Alcoholism: Clinical and Experimental Research. DOI PubMed
  3. ReviewGundermann KJ, Kuenker A, Kuntz E, Droździk M (2016). Activity of essential phospholipids (EPL) from soybean in liver diseases. Pharmacological Reports. DOI PubMed
  4. Li J, Li Y, Wang J, Zhou Y, et al. (2025). Genetic evidence reveals phosphatidylcholine as a mediator in the causal relationship between omega-3 and multiple myeloma risk.. Scientific reports. DOI PubMed
  5. Meta-analysisStremmel W, Vural H, Evliyaoglu O, Weiskirchen R (2022). [Efficacy of enteric lecithin (phosphatidylcholine) in the treatment of ulcerative colitis: a meta-analysis].. MMW Fortschritte der Medizin. DOI PubMed
  6. Meta-analysisStremmel W, Vural H, Evliyaoglu O, Weiskirchen R (2021). Delayed-Release Phosphatidylcholine Is Effective for Treatment of Ulcerative Colitis: A Meta-Analysis.. Digestive diseases (Basel, Switzerland). DOI PubMed
  7. Mora-Ortiz M, Yubero-Serrano EM, Priego-Capote F, Gutierrez-Mariscal FM, et al. (2024). Dietary Lipid Quantity and Quality Modulate the Postprandial Metabolomic Profile in Patients with Metabolic Syndrome.. Nutrients. DOI PubMed
Show 3 more references
  1. Li CZ, Wu LM, Zhu CX, Du HY, et al. (2024). The impacts of dietary sphingomyelin supplementation on metabolic parameters of healthy adults: a systematic review and meta-analysis of randomized controlled trials.. Frontiers in nutrition. DOI PubMed
  2. Bantugan MA, Xian H, Solomon V, Lee M, et al. (2023). Associations of ApoE4 status and DHA supplementation on plasma and CSF lipid profiles and entorhinal cortex thickness.. Journal of lipid research. DOI PubMed
  3. Jin T, Kang G, Song S, Lee H, et al. (2023). The effects of dietary self-monitoring intervention on anthropometric and metabolic changes via a mobile application or paper-based diary: a randomized trial.. Nutrition research and practice. DOI PubMed